Correlation Between Qualigen Therapeutics and CF Acquisition
Can any of the company-specific risk be diversified away by investing in both Qualigen Therapeutics and CF Acquisition at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Qualigen Therapeutics and CF Acquisition into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Qualigen Therapeutics and CF Acquisition Corp, you can compare the effects of market volatilities on Qualigen Therapeutics and CF Acquisition and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Qualigen Therapeutics with a short position of CF Acquisition. Check out your portfolio center. Please also check ongoing floating volatility patterns of Qualigen Therapeutics and CF Acquisition.
Diversification Opportunities for Qualigen Therapeutics and CF Acquisition
-0.42 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Qualigen and CFIVW is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Qualigen Therapeutics and CF Acquisition Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CF Acquisition Corp and Qualigen Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Qualigen Therapeutics are associated (or correlated) with CF Acquisition. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CF Acquisition Corp has no effect on the direction of Qualigen Therapeutics i.e., Qualigen Therapeutics and CF Acquisition go up and down completely randomly.
Pair Corralation between Qualigen Therapeutics and CF Acquisition
If you would invest 8.00 in CF Acquisition Corp on September 1, 2024 and sell it today you would earn a total of 0.00 from holding CF Acquisition Corp or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 4.76% |
Values | Daily Returns |
Qualigen Therapeutics vs. CF Acquisition Corp
Performance |
Timeline |
Qualigen Therapeutics |
CF Acquisition Corp |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Qualigen Therapeutics and CF Acquisition Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Qualigen Therapeutics and CF Acquisition
The main advantage of trading using opposite Qualigen Therapeutics and CF Acquisition positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Qualigen Therapeutics position performs unexpectedly, CF Acquisition can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CF Acquisition will offset losses from the drop in CF Acquisition's long position.Qualigen Therapeutics vs. ZyVersa Therapeutics | Qualigen Therapeutics vs. Immix Biopharma | Qualigen Therapeutics vs. Phio Pharmaceuticals Corp | Qualigen Therapeutics vs. 180 Life Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |